CELLINK is now publicly listed on the Nasdaq Main Market under the ticker: CLNK. This is an incredibly exciting step on our journey to change the world with innovative technologies, and we couldn’t have done it without the support of our customers, the trust of our shareholders, and the phenomenal skills of our hard-working global team.
We started CELLINK in 2016 to help scientists revolutionize their work in research. Today, we’re an international company working to maximize the impact of groundbreaking life-science research with technologies that disrupt entire industries with offices in 6 countries, products in 55 countries, and more than 200 colleagues. To do this, we’ve focused since day one on delivering innovative solutions that our users can count on, at an affordable price.
Today’s IPO strengthens the powerful platform that we’ve built and invigorates our ambitious visions for what we will achieve. We are grateful to every member of the CELLINK team for your role in making our organization what it is today. A huge thank you to all of CELLINK’s customers, shareholders, and investors for your trust and partnership. Let’s celebrate this milestone and get ready for all that lies ahead! LET’S GO CELLINK!